|
1
|
Parkin DM, Bray F, Ferlay J and Pisani P:
Global cancer statistics, 2002. CA Cancer J Clin. 55:74–108. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Park NH and Chung YH: Molecular mechanisms
of hepatitis B virus-associated hepatocellular carcinoma. Korean J
Hepatol. 13:320–340. 2007.(In Korean). View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Chen CJ, Yang HI, Su J, Jen CL, You SL, Lu
SN, Huang GT and Iloeje UH; REVEAL-HBV Study Group. Risk of
hepatocellular carcinoma across a biological gradient of serum
hepatitis B virus DNA level. JAMA. 295:65–73. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Taylor-Robinson SD, Foster GR, Arora S,
Hargreaves S and Thomas HC: Increase in primary liver cancer in the
UK, 1979–94. Lancet. 350:1142–1143. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Deuffic S, Poynard T, Buffat L and
Valleron AJ: Trends in primary liver cancer. Lancet. 351:214–215.
1998. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
El-Serag HB and Mason AC: Rising incidence
of hepatocellular carcinoma in the United States. N Engl J Med.
340:745–750. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Taketa K: Alpha-fetoprotein: Reevaluation
in hepatology. Hepatology. 12:1420–1432. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Chen DS, Sung JL, Sheu JC, Lai MY, How SW,
Hsu HC, Lee CS and Wei TC: Serum alpha-fetoprotein in the early
stage of human hepatocellular carcinoma. Gastroenterology.
86:1404–1409. 1984.PubMed/NCBI
|
|
9
|
Lok AS and Lai CL: alpha-Fetoprotein
monitoring in Chinese patients with chronic hepatitis B virus
infection: Role in the early detection of hepatocellular carcinoma.
Hepatology. 9:110–115. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Tsai SL, Huang GT, Yang PM, Sheu JC, Sung
JL and Chen DS: Plasma des-gamma-carboxyprothrombin in the early
stage of hepatocellular carcinoma. Hepatology. 11:481–488. 1990.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Soga K, Watanabe T, Aikawa K, Toshima M,
Shibasaki K and Aoyagi Y: Serum des-gamma-carboxyprothrombin level
by a modified enzyme immunoassay method in hepatocellular
carcinoma: Clinical significance in small hepatocellular carcinoma.
Hepatogastroenterology. 45:1737–1741. 1998.PubMed/NCBI
|
|
12
|
Lee IN, Chen CH, Sheu JC, Lee HS, Huang
GT, Chen DS, Yu CY, Wen CL, Lu FJ and Chow LP: Identification of
complement C3a as a candidate biomarker in human chronic hepatitis
C and HCV-related hepatocellular carcinoma using a proteomics
approach. Proteomics. 6:2865–2873. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Feng JT, Liu YK, Song HY, Dai Z, Qin LX,
Almofti MR, Fang CY, Lu HJ, Yang PY and Tang ZY: Heat-shock protein
27: A potential biomarker for hepatocellular carcinoma identified
by serum proteome analysis. Proteomics. 5:4581–4588. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Görg A, Obermaier C, Boguth G, Harder A,
Scheibe B, Wildgruber R and Weiss W: The current state of
two-dimensional electrophoresis with immobilized pH gradients.
Electrophoresis. 21:1037–1053. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Gygi SP, Rist B, Gerber SA, Turecek F,
Gelb MH and Aebersold R: Quantitative analysis of complex protein
mixtures using isotope-coded affinity tags. Nat Biotechnol.
17:994–999. 1999. View
Article : Google Scholar : PubMed/NCBI
|
|
16
|
Mirgorodskaya OA, Kozmin YP, Titov MI,
Körner R, Sönksen CP and Roepstorff P: Quantitation of peptides and
proteins by matrix-assisted laser desorption/ionization mass
spectrometry using 18O-labeled internal standards. Rapid
Commun Mass Spectrom. 14:1226–1232. 2000. View Article : Google Scholar
|
|
17
|
Ross PL, Huang YN, Marchese JN, Williamson
B, Parker K, Hattan S, Khainovski N, Pillai S, Dey S, Daniels S, et
al: Multiplexed protein quantitation in Saccharomyces cerevisiae
using amine-reactive isobaric tagging reagents. Mol Cell
Proteomics. 3:1154–1169. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Rai AJ, Gelfand CA, Haywood BC, Warunek
DJ, Yi J, Schuchard MD, Mehigh RJ, Cockrill SL, Scott GB, Tammen H,
et al: HUPO Plasma Proteome Project specimen collection and
handling: Towards the standardization of parameters for plasma
proteome samples. Proteomics. 5:3262–3277. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Lok AS and McMahon BJ: Chronic hepatitis
B: Update 2009. Hepatology. 50:661–662. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Liaw YF, Leung N, Kao JH, Piratvisuth T,
Gane E, Han KH, Guan R, Lau GK and Locarnini S; Chronic Hepatitis B
Guideline Working Party of the Asian-Pacific Association for the
Study of the Liver. Asian-Pacific consensus statement on the
management of chronic hepatitis B: A 2012 update. Hepatol Int.
6:531–561. 2012. View Article : Google Scholar
|
|
21
|
European Association for the Study of the
Liver. EASL clinical practice guidelines on the management of
ascites, spontaneous bacterial peritonitis, and hepatorenal
syndrome in cirrhosis. J Hepatol. 53:397–417. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Bruix J and Sherman M; American
Association for the Study of Liver Diseases. Management of
hepatocellular carcinoma: An update. Hepatology. 53:1020–1022.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Yang Y, Lim SK, Choong LY, Lee H, Chen Y,
Chong PK, Ashktorab H, Wang TT, Salto-Tellez M, Yeoh KG, et al:
Cathepsin S mediates gastric cancer cell migration and invasion via
a putative network of metastasis-associated proteins. J Proteome
Res. 9:4767–4778. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Tong SW, Yang YX, Hu HD, An X, Ye F, Hu P,
Ren H, Li SL and Zhang DZ: Proteomic investigation of
5-fluorouracil resistance in a human hepatocellular carcinoma cell
line. J Cell Biochem. 113:1671–1680. 2012.
|
|
25
|
Yang Y, Toy W, Choong LY, Hou P, Ashktorab
H, Smoot DT, Yeoh KG and Lim YP: Discovery of SLC3A2 cell membrane
protein as a potential gastric cancer biomarker: Implications in
molecular imaging. J Proteome Res. 11:5736–5747. 2012.PubMed/NCBI
|
|
26
|
Ho J, Kong JW, Choong LY, Loh MC, Toy W,
Chong PK, Wong CH, Wong CY, Shah N and Lim YP: Novel breast cancer
metastasis-associated proteins. J Proteome Res. 8:583–594. 2009.
View Article : Google Scholar
|
|
27
|
Lepiller Q, Abbas W, Kumar A, Tripathy MK
and Herbein G: HCMV activates the IL-6-JAK-STAT3 axis in HepG2
cells and primary human hepatocytes. PLoS One. 8:e595912013.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Tong SW, Yang YX, Hu HD, An X, Ye F, Ren
H, Li SL and Zhang DZ: HSPB1 is an intracellular antiviral factor
against hepatitis B virus. J Cell Biochem. 114:162–173. 2013.
View Article : Google Scholar
|
|
29
|
Schmittgen TD and Livak KJ: Analyzing
real-time PCR data by the comparative C(T) method. Nat Protoc.
3:1101–1108. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Gan CS, Chong PK, Pham TK and Wright PC:
Technical, experimental, and biological variations in isobaric tags
for relative and absolute quantitation (iTRAQ). J Proteome Res.
6:821–827. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zhou C, Simpson KL, Lancashire LJ, Walker
MJ, Dawson MJ, Unwin RD, Rembielak A, Price P, West C, Dive C, et
al: Statistical considerations of optimal study design for human
plasma proteomics and biomarker discovery. J Proteome Res.
11:2103–2113. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Xie TX, Wei D, Liu M, Gao AC, Ali-Osman F,
Sawaya R and Huang S: Stat3 activation regulates the expression of
matrix metalloproteinase-2 and tumor invasion and metastasis.
Oncogene. 23:3550–3560. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Yu H, Pardoll D and Jove R: STATs in
cancer inflammation and immunity: A leading role for STAT3. Nat Rev
Cancer. 9:798–809. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Yang J, Wezeman M, Zhang X, Lin P, Wang M,
Qian J, Wan B, Kwak LW, Yu L and Yi Q: Human C-reactive protein
binds activating Fcgamma receptors and protects myeloma tumor cells
from apoptosis. Cancer Cell. 12:252–265. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Hefler LA, Concin N, Hofstetter G, Marth
C, Mustea A, Sehouli J, Zeillinger R, Leipold H, Lass H, Grimm C,
et al: Serum C-reactive protein as independent prognostic variable
in patients with ovarian cancer. Clin Cancer Res. 14:710–714. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Xu M, Zhu M, Du Y, Yan B, Wang Q, Wang C
and Zhao J: Serum C-reactive protein and risk of lung cancer: A
case-control study. Med Oncol. 30:3192013. View Article : Google Scholar
|
|
37
|
Nozoe T, Matsumata T, Kitamura M and
Sugimachi K: Significance of preoperative elevation of serum
C-reactive protein as an indicator for prognosis in colorectal
cancer. Am J Surg. 176:335–338. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Fujikawa K, Matsui Y, Oka H, Fukuzawa S
and Takeuchi H: Serum C-reactive protein level and the impact of
cytoreductive surgery in patients with metastatic renal cell
carcinoma. J Urol. 162:1934–1937. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Nozoe T, Saeki H and Sugimachi K:
Significance of preoperative elevation of serum C-reactive protein
as an indicator of prognosis in esophageal carcinoma. Am J Surg.
182:197–201. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Mantovani A, Allavena P, Sica A and
Balkwill F: Cancer-related inflammation. Nature. 454:436–444. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Heikkilä K, Ebrahim S and Lawlor DA: A
systematic review of the association between circulating
concentrations of C reactive protein and cancer. J Epidemiol
Community Health. 61:824–833. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Tschopp J, Podack ER and Müller-Eberhard
HJ: Ultrastructure of the membrane attack complex of complement:
Detection of the tetramolecular C9-polymerizing complex C5b-8. Proc
Natl Acad Sci USA. 79:7474–7478. 1982. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Urieli-Shoval S, Linke RP and Matzner Y:
Expression and function of serum amyloid A, a major acute-phase
protein, in normal and disease states. Curr Opin Hematol. 7:64–69.
2000. View Article : Google Scholar
|
|
44
|
Betts JC, Cheshire JK, Akira S, Kishimoto
T and Woo P: The role of NF-kappa B and NF-IL6 transactivating
factors in the synergistic activation of human serum amyloid A gene
expression by interleukin-1 and interleukin-6. J Biol Chem.
268:25624–25631. 1993.PubMed/NCBI
|
|
45
|
Migita K, Kawabe Y, Tominaga M, Origuchi
T, Aoyagi T and Eguchi K: Serum amyloid A protein induces
production of matrix metalloproteinases by human synovial
fibroblasts. Lab Invest. 78:535–539. 1998.PubMed/NCBI
|
|
46
|
Li Y, Cai L, Wang H, Wu P, Gu W, Chen Y,
Hao H, Tang K, Yi P, Liu M, et al: Pleiotropic regulation of
macrophage polarization and tumorigenesis by formyl peptide
receptor-2. Oncogene. 30:3887–3899. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Kim H, Meyer K, Di Bisceglie AM and Ray R:
Hepatitis C virus suppresses C9 complement synthesis and impairs
membrane attack complex function. J Virol. 87:5858–5867. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Chong PK, Lee H, Loh MC, Choong LY, Lin Q,
So JB, Lim KH, Soo RA, Yong WP, Chan SP, et al: Upregulation of
plasma C9 protein in gastric cancer patients. Proteomics.
10:3210–3221. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Narayanasamy A, Ahn JM, Sung HJ, Kong DH,
Ha KS, Lee SY and Cho JY: Fucosylated glycoproteomic approach to
identify a complement component 9 associated with squamous cell
lung cancer (SQLC). J Proteomics. 74:2948–2958. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Ferrín G, Ranchal I, Llamoza C,
Rodríguez-Perálvarez ML, Romero-Ruiz A, Aguilar-Melero P,
López-Cillero P, Briceño J, Muntané J, Montero-Álvarez JL, et al:
Identification of candidate biomarkers for hepatocellular carcinoma
in plasma of HCV-infected cirrhotic patients by 2-D DIGE. Liver
Int. 34:438–446. 2013. View Article : Google Scholar : PubMed/NCBI
|
